Skip to main content

Table 1 Demographic and endpoint data of the two groups

From: Does a medical management program for CKD patients postpone renal replacement therapy and mortality?: A 5-year-cohort study

 

Group1

Group2

P value

 

Control group (76)

treated group (389)

CKD stage number(percent)

  

0.99

3a:60>GFR≥45

14(18.4)

140(36.0)

 

3b:45>GFR≥30 number(percent)

35(46.1)

180(46.3)

 

4:30>GFR≥15 number(percent)

27(35.5)

69(17.7)

 

(GFRcc/min/1.73m2)

   

CKD stage (RRT+death)/total(%)

  

0.048*

3a:

(3+0)/14(21.4)

34.66±11.03

 

3b:

(9+2)/35(31.4)

(11+5)/180(8.9)

 

4:

(5+1)/27(22.2)

(5+1)/69(8.7)

 

GFRcc/min/1.73m2 mean±SD

35.09±10.56

(38+7)/140(32.1)

0.753

Age(years) mean±SD

56.5±17.3

62.3±14.2

0.008*

Diabetes mellitus

23(30.3%)

130(33.4%)

0.328

Sex(Male/Female)

43/33=1.3

234/155=1.5

0.324

Anemia(Hb<11gr/dl)

13/48

42/203

0.218

Systolic HTN(>14CmHg)

32/60

113/312

0.010*

Systolic Blood pressure (CmHg) mean±SD

14.91±2.85

13.82±2.68

0.005*

Diastolic Blood pressure (CmHg) mean±SD

8.34±1.47

7.74±1.30

0.001*

Hemoglobin(gr/dl) mean±SD

12.58±2.51

12.61±2.03

0.913

Calcium(mg/dl) mean±SD

9.12±0.70

9.22±1.00

0.681

Phosphorus(mg/dl) mean±SD

4.30±1.07

4.04±0.77

0.348

Uric acid(mg/dl) mean±SD

7.45±1.84

9.46±12.84

0.549

Cholesterol(mg/dl) mean±SD

209.56±57.66

196.19±69.14

0.251

Triglyceride(mg/dl) mean±SD

266.14±181.11

192.40±119.00

0.048